Board Investigation

6. As part of its investigation, the Board obtained the Respondent’s quality
assurance file from the Facility, interviewed several staff members from the Facility, and
referred the Respondent for an evaluation.

The Respondent’s quality assurance file

7. The Respondent’s quality assurance file notes that on or about March 20,
2020, the Facility informed the Respondent that it had received several individual reports
about him involving forgetfulness and possible practice irregularities. As a result of these
concerns, the Facility referred the Respondent for a fitness-for-duty evaluation. In
conjunction with this referral, the Respondent agreed to take a medical leave of absence.
On March 23, 2020, the Respondent submitted to the evaluation, after which the
evaluator issued a report of his findings.’

8. In or around July 2021, the Facility received information that the
Respondent was continuing to practice medicine despite his medical leave of absence. In
a letter dated July 26, 2021, the Facility informed the Respondent that he was continuing
to provide patient care that included providing medical advice to patients and
consultation services to community physicians at other health care facilities, including
recommendations for medical and pharmacologic management of inpatients. The

Facility further instructed the Respondent to cease and desist from these actions.

* For confidentiality reasons, the specific information contained in the report will not be disclosed in this
document. This information will be disclosed to the Respondent upon request. The Panel was aware of
this information at the time it voted to summarily suspend the Respondent’s medical license.
